Legal Advantage Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.38M | Buy |
8,329
+100
| +1% | +$40.5K | 1.58% | 27 |
|
|
2025
Q1 | $4.09M | Buy |
8,229
+200
| +2% | +$99.5K | 2.21% | 14 |
|
|
2024
Q4 | $4.18M | Sell |
8,029
-125
| -2% | -$65K | 2.21% | 13 |
|
|
2024
Q3 | $5.04M | Sell |
8,154
-45
| -0.5% | -$27.8K | 2.77% | 9 |
|
|
2024
Q2 | $4.53M | Hold |
8,199
| – | – | 2.61% | 12 |
|
|
2024
Q1 | $4.77M | Hold |
8,199
| – | – | 2.67% | 10 |
|
|
2023
Q4 | $4.35M | Buy |
8,199
+42
| +0.5% | +$22.3K | 2.62% | 11 |
|
|
2023
Q3 | $4.13M | Sell |
8,157
-88
| -1% | -$44.5K | 2.95% | 9 |
|
|
2023
Q2 | $4.3M | Buy |
8,245
+425
| +5% | +$222K | 2.87% | 8 |
|
|
2023
Q1 | $4.51M | Buy |
7,820
+35
| +0.4% | +$20.2K | 3.31% | 6 |
|
|
2022
Q4 | $4.29M | Hold |
7,785
| – | – | 3.52% | 4 |
|
|
2022
Q3 | $3.95M | Buy |
7,785
+85
| +1% | +$43.1K | 3.7% | 4 |
|
|
2022
Q2 | $4.18M | Buy |
7,700
+500
| +7% | +$272K | 4.08% | 4 |
|
|
2022
Q1 | $4.25M | Buy |
7,200
+125
| +2% | +$73.8K | 3.2% | 6 |
|
|
2021
Q4 | $4.72M | Sell |
7,075
-120
| -2% | -$80.1K | 3.2% | 8 |
|
|
2021
Q3 | $4.11M | Buy |
7,195
+100
| +1% | +$57.1K | 2.76% | 11 |
|
|
2021
Q2 | $3.58M | Buy |
7,095
+2
| +0% | +$1.01K | 2.45% | 14 |
|
|
2021
Q1 | $3.24M | Buy |
7,093
+10
| +0.1% | +$4.56K | 2.42% | 13 |
|
|
2020
Q4 | $3.3M | Buy |
+7,083
| New | +$3.3M | 2.57% | 13 |
|